Outcome of oral bosentan in children with congenital heart disease associated pulmonary arterial hypertension

To investigate the outcome of dual endothelin receptor antagonist bosentan in children with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH). A total of 32 children were recruited into this prospective and observational study. Among them, there were 18 cases with left-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Zhong hua yi xue za zhi 2009-08, Vol.89 (30), p.2106-2109
Hauptverfasser:	Xu, Zhuo-ming, Zhu, Li-Min, Cai, Xiao-Man, Ji, Gang, Liu, Jin-Fen, Su, Zhao-Kang
Format:	Artikel
Sprache:	chi
Schlagworte:	Adolescent Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Child Child, Preschool Female Follow-Up Studies Heart Defects, Congenital - complications Heart Defects, Congenital - drug therapy Humans Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - etiology Infant Male Prospective Studies Sulfonamides - adverse effects Sulfonamides - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!